TY  - GEN
AU  - Mamlouk,K
AU  - Saracino,G
AU  - Berryman,R B
AU  - Fay,J W
AU  - Pineiro,L A
AU  - Vance,E A
AU  - White,M
AU  - Sandler,I
AU  - Agura,E D
TI  - Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring
SN  - 0268-3369
PY  - 2005///0728
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Area Under Curve
KW  - Busulfan
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Female
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Radiometry
KW  - Retrospective Studies
KW  - Time Factors
KW  - Transplantation Conditioning
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1704871
ER  -